Allscripts (MDRX) Tops Q2 EPS by 6c

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.23, $0.06 better than the analyst estimate of $0.17. Revenue for the quarter came in at $374 million versus the consensus estimate of $373.45 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MP Materials seen largely insulated after China export-control move
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform